CN1422663A - Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method - Google Patents
Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method Download PDFInfo
- Publication number
- CN1422663A CN1422663A CN 02158103 CN02158103A CN1422663A CN 1422663 A CN1422663 A CN 1422663A CN 02158103 CN02158103 CN 02158103 CN 02158103 A CN02158103 A CN 02158103A CN 1422663 A CN1422663 A CN 1422663A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- powder
- granule
- weight portions
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a Chinese medicine preparation with the functions of relieving sore-throat, subduing swelling and stopping pain for curing sore-throat, hoarseness, tonsillitis, aphthous stomatitis, ulcerative stomatitis, toothache, acute and chronic laryngopharyngitis, acute tonsilitis and gingival swelling and pain, etc. It is made from the Chinese medicinal materials of watermelon cream, borneol, methanol and oleum menthae as raw material, and has good therapeutic effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation and preparation method thereof, particularly relate to a kind of Chinese medicine preparation of preventing and treating throat and oral cavity diseases and preparation method thereof.
Background technology
Throat and oral cavity diseases belongs to traditional Chinese medical science categories such as " tonsillitis, erosion of the oral mucosa, sore throat, gingival abscess, tongue boils ", be subordinate to ability to speak, larynx section, diseases such as the said acute and chronic pharyngitis of modern medicine, acute tonsillitis, oral ulcer, stomatitis, gingival swelling and pain, pathogeny Chinese medicine is thought " all diseases of throat all belong to fire ", mainly be body diseases caused by exogenous pathogenic factor pyretic toxicity and cause on the pathogenic fire scorchingly, or cause exopathogen because oral cavity and throat is unclean and invade.Moreover be exactly that plain body loses void, and cause hyperactivity of deficient fire.Modern medicine study thinks that the scorching card of oral cavity and throat disease mainly is an infected by microbes such as antibacterial, virus and causing, or body immunity is low, and antibacterial, virus are in the pathogenic microorganism growth imbalance of oral cavity and throat and cause infection.Also have due to the mechanical damage simultaneously.Primary disease can take place throughout the year, and can repeatedly take place.The tradition Chinese medicine has much the commentary treatise of oral cavity throat disease, has also put down in writing many prescriptions, and as Yangyin Qingfei Tang, BINGPENG SAN etc., these prescriptions are to adopt according to concrete symptom, are the important component parts of Chinese medicine content.Ancient Chinese medicine medicine or Chinese medicine among the people are fully being summed up, excavating or utilized to the modern Chinese medicine theory also.Just introduce the many proved recipes of control oral cavity and throat diseases, typical prescription as Chinese medicine institution of higher learning teaching material " traditional Chinese medical science otolaryngology ", the control oral cavity and throat diseases is had directive function preferably.Some pharmaceutical factories and Chinese medicine research institution also release some medicines in recent years, and as toothache killer pill, folk song buccal tablet etc., but these Chinese medicine effects differ, the selling at exorbitant prices that has, and the specific aim that has is not strong, and curative effect is unsatisfactory.Chinese patent also discloses many medicines that prevent oral cavity and throat diseases, as 99115242.5 patent documentations, a kind of Chinese medicine for the treatment of pharyngolaryngitis, by Chinese medicine Radix Achyranthis Bidentatae and Herba Houttuyniae through selecting materials pulverizing, sterilization, packed forming.99117145.4, disclosing a kind of pure medical herbs for the treatment of throat disease efficiently looses, 99120049.7, disclosing with beaver bile, Fructus Momordicae, Mentholum is primary raw material, be aided with gelatin, starch, glucose, stevioside, glycerol, potassium sorbate thick film sheet, for the usefulness that contains food through being processed into.01,128,346 1 kinds of health medicine and production methods thereof for the treatment of oral cavity and laryngopharyngeal diseases, it comprises raw material of Chinese medicine such as Flos Lonicerae, Flos Chrysanthemi, Radix Isatidis, Herba Hedyotidis Diffusae, Radix Platycodonis, Periostracum Cicadae, Flos Ilicis Asprellae, Herba Taraxaci, Radix Glycyrrhizae.The prescription too complex that the prescription of said medicine has, the curative effect that does not have production method, has that has are definite inadequately, and it is narrow to adapt to sick spectrum, thereby promote the use of and be subjected to certain restriction.
Summary of the invention
The object of the invention is to provide Chinese medicine preparation of the immoderate control throat and oral cavity diseases of a kind of determined curative effect, steady quality, safety and preparation method thereof.
The present invention seeks to be achieved through the following technical solutions:
Watermelon crystal 19～90 weight portions, Borneolum Syntheticum 0.01～1.5 weight portion, Oleum menthae 0.01～2.5 weight portion, Mentholum 0.02～3 weight portion, wherein the watermelon crystal water content 20～80%, contain the above-mentioned raw materials medicine, can add conventional adjuvant and make clinical acceptable forms, as buccal tablet, effervescent tablet, oral liquid, drop pill, paster, capsule, granule, spray.
Preferred watermelon crystal 38 weight portions of crude drug, Borneolum Syntheticum 1.2 weight portions, Mentholum 2.4 weight portions, Oleum menthae 2.0 weight portions.
The preparation method of watermelon crystal buccal tablet of the present invention:
Get clean watermelon crystal, the oven dry, pulverize fine powder, get sucrose (also can be lactose, maltose, sorbitol, mannitol etc.) 900-1200 weight portion, pulverize 60～120 mesh sieves, must get the sterilization of watermelon crystal powder, oven dry, take out, be ground into fine powder, the operation recovery rate answers 〉=97%; Get watermelon crystal fine powder 20-30 weight portion, cane sugar powder (or lactose powder or maltitol powder or sorbitol powder or mannitol powder etc.) 1000-1200 weight portion, dextrin 20-40 weight portion, put and stir evenly 3～20 minutes in the blender, with 0.1-0.3 weight portion carmine and 0.6-1 weight portion citric acid, filter with an amount of dissolved in distilled water, the 30%-40% alcohol mixed solution that adds filtering carmine and citric acid weight portion stirs more than 6-10 minute, granulate, drying makes dried granule moisture content in 0.3%.With Borneolum Syntheticum; Mentholum; behind 95% dissolve with ethanol, with Oleum menthae, the essence mixing; filtering the back adds in the granule; cross pelletizing machine, the magnesium stearate that the 0.2-1% granule is heavy, the silicon dioxide that the 0.2-1% granule is heavy sucks in the V-Mixer with 1-4% Pulvis Talci and granule after crossing 60～150 mesh sieves; mixed 5～15 minutes, airtight more than 2～5 hours hours.Granule is pressed into tablet.
Buccal tablet of the present invention utilizes modern crafts to make tablet, effect with clearing throat, reducing swelling and alleviating pain, be mainly used in control laryngopharynx swelling and pain, hoarseness, laryngalgia, throat moth, erosion of the oral mucosa, aphtha of the mouth and tongue, toothache, diseases such as acute and chronic pharyngitis, acute tonsillitis, oral ulcer, stomatitis, gingival swelling and pain, evident in efficacy, treat the disease spectrum width.
(Waterelon Frost Lozenges passed through 3 tame hospitals, 415 routine clinical verifications such as Affiliated Hospital of Medical Colleges Of Guilin in 1992 to buccal tablet of the present invention, wherein treatment group sore throat 224 examples, tonsillitis 83 examples, erosion of the oral mucosa 12 examples, 3 examples of having a toothache, curative effect is respectively 93.3%, 96.4%, 91.7%, 100%, with the matched group contrast significant difference (p＜0.05) is arranged.Carried out 160 routine clinical verifications in 1997 in the People's Hospital, Guilin City, treatment tonsillitis (accumulated heat in the lung and stomach), aphtha (excess syndrome) are wherein treated tonsillitis 80 examples, and 50 examples are organized in treatment, total effective rate 94.00%, total obvious effective rate 66.00%; Treatment aphtha 80 examples, 50 examples are organized in treatment, total effective rate 94.00%, total obvious effective rate 78.00%: both treatment groups are all a little more than matched group, but there was no significant difference.
Do not see obvious adverse reaction and toxic and side effects during clinical observation, the clinical verification data shows: this medicine has the effect of sore throat relieving sore-throat relieving, reducing swelling and alleviating pain.Clinical application is safe, and its prescription, dosage form are reasonably, treat the disease spectrum width, and good mouthfeel, melting time are long, and taking convenience can continue medication, and is easy to carry about with one.
Experimental example 1:Waterelon Frost Lozenges treatment chronic pharyngitis
Clinical data: (Ministry of Health of the People's Republic of China develops and publishes according to " the clinical research guideline of new Chinese medicine treatment chronic pharyngitis ", diagnosis 1993:308) and criterion of therapeutical effect, select the course of disease more than two months, often have chronic pharyngitis to show effect repeatedly, pharyngeal antibacterial culturing have the pathogenic bacterium person totally 60 examples as the object of observation.
Therapeutic Method: the treatment group is with containing of Waterelon Frost Lozenges, and each 3, every day 3 times.Evaluate curative effect 7 days courses of treatment.Reach the medicine of relevant treatment primary disease during the treatment without antibiotic.
Therapeutic outcome: sings and symptoms disappears after produce effects-medication.Effectively-disappearance of medication rear section sings and symptoms.Invalid-as not reach the responder.
Total effects: treatment group produce effects 18 examples (37.50%), effective 25 examples (52.08%), invalid 5 examples (10.42%); Treatment group total effective rate 89.58%.
Experimental example 2:The Waterelon Frost Lozenges antibacterial action:
Plate dilution method proves, this compound recipe is to first type, group B streptococcus, streptococcus pneumoniae, and the minimum inhibitory concentration of Candida albicans is 25mg/ml; Then need double (50mg/ml) to first type, group B streptococcus bacteriocidal concentration, and consistent to back two kinds of antibacterials (streptococcus pneumoniae and Candida albicans) sterilization and Mlc; To golden Fructus Vitis viniferae, bacteriocidal concentration is 50mg/ml.
1, antiinflammatory experiment gained result shows that Waterelon Frost Lozenges has stronger anti-inflammation detumescence effect.
Local coating Waterelon Frost Lozenges can resist the Mice Auricle inflammation due to the Oleum Tiglii: its antiphlogistic effects is suitable with the effect of local coating andrographolide (0.75) when being coated with 1 time (10mg); The effect that is coated with 2 times is then better.The ig Waterelon Frost Lozenges can resist the formation of the subcutaneous granuloma induced by implantation of cotton pellets of mice continuously, but shows the propagation phase reaction of this compound recipe ig inflammation-inhibiting.
2, experiment (the intradermal injection Waterelon Frost Lozenges suspension) result Cavia porcellus shows that this compound recipe has certain local anesthesia analgesic effect.
3, give mice in 6 hours, ig3 time continuously, total amount reaches 12g/kg, can cause 10% animal dead (be limited to liquor strength, be difficult to escalated dose again).Such minimal toxic dose is compared with clinical consumption, has been more than 1000 times of human dosage, is enough to illustrate that this compound recipe toxicity is very little, and clinical practice is safe.
Experimental example 3:The Waterelon Frost Lozenges antivirus action
1. Waterelon Frost Lozenges is to the influence of pathological changes caused by virus effect (CPE)
Diploid passage cell (HDC) is inoculated in each hole of trace cell plates, 96 holes (100 μ l/ hole) according to a conventional method, put in 37 ℃ of CO2 incubators and cultivated 3 days, inoculate FM1 respectively after growing up to monolayer, HSV-1), A3,4 kinds of viruses such as ECHoll (inoculum concentration sees Table) are after 37 ℃ of absorption, add different dilution factor medicinal liquids (each 4 hole), be located at no medicine virus control, normal cell contrast, positive cell contrast, the contrast of positive antiviral drugs and the contrast of toxic effect valency etc. simultaneously.Put in 37 ℃ of CO2 incubators and cultivate, every day, microscopy write down the cytopathy situation, for three days on end.
The result shows, 1: 20 (being equivalent to crude drug in whole 0.0685g/ml) of Waterelon Frost Lozenges, to influenza virus FM1, herpes simplex virus HSV-1 and adenovirus A3 institute cytopathogenic effect, the obvious suppression effect is arranged, but to the sick ECHOll unrestraint effect (seeing Table 1) of intestinal
Table 1 Waterelon Frost Lozenges (throat lozenge) is other to the influence of pathological changes caused by virus effect
First day second day the 3rd day cell of medicine and concentration contrasts 0 0,000 0,000 0000
Ribavirin 0,000 0,000 0000 FM1 throat lozenge 1: 10 0,000 0,000 0000 (10TCID50) 1: 20 0,000 0,000 0000
1∶40 0000 2101 2212
1: 80 0,000 2101 3212FM1 virus control 0 0,000 2,112 3223
Ribavirin 0,000 0,000 0000 HSV-1 throat lozenge 1: 10 0,000 0,000 0000 (10TCID50) 1: 20 0,000 0,000 0000
1∶40 0000 1000 4133
1: 80 0,000 2122 4333HSV-1 virus control 0 0,000 2,323 4444
Ribavirin 0,000 0,000 0000 A3 throat lozenge 1: 10 0,000 0,000 0000 (100TCID50) 1: 20 0,000 0,000 0000
1∶40 0000 1000 2010
1: 80 0,000 2133 4334A3 virus control 0 0,000 2,323 4444
Ribavirin 0,000 1,000 2112 BCHOll throat lozenge 1: 10 111＜1 2,333 4444 (100TCID50) 1: 20 3,333 4,444 4444
1∶40 3344 4444 4444
1: 80 4,444 4444 4444BCHO11 virus control 0 4,444 4,444 4444
Annotate: cytopathy (CPE) classification: "＜1 " sick cell less than 5%, " 1 " sick cell accounts for 5%-25%." 2 " sick cell accounts for 25%-50%, and " 3 " sick cell accounts for 50%-75%, and " 4 " sick cell reaches 75%-100%.The cell of the sick change of " 0 " expression.
2. Waterelon Frost Lozenges is to the influence of virus in the cell internal breeding
Indirect immunofluorescence is carried out routinely, the Hep-1 cell plates that will grow up to monolayer, infect FM1 or HSV-1 (being 100TCID50) respectively, after putting in 37 ℃ of CO2 incubators absorption 1h, use 0.01mol/L, the PBS buffer flush away free virus of PH7.4, adding the liquid of keeping that contains different doses continues to cultivate, go the hole pastille to keep liquid respectively at absorption back 5,8,10, each suction of 12h, wash 2 times, add fixedly 10min of 95% ethanol with PBS.During dyeing, earlier add anti-FM1 of corresponding rabbit or HSV-1 immune serum respectively, put 37 ℃ and cultivate 2h, take out and wash with PBS, add goat anti-rabbit igg-FITCC traget antibody again, cultivate with above-mentioned same method, rinsing is observed the specific fluorescence cell concentration with epifluorescence microscope at last and (is divided into 5 grades according to the ratio that accounts for whole cell face, " 0 ": 0% " 1 ": less than 5%, " 2 ": 5-10%, " 3 ": 10-30%, " 4 ":＞30%).See Table 2
Table 2 Waterelon Frost Lozenges (throat lozenge) is to the influence of virus in the cell internal breeding
1: 10 0,000 1,001 1,011 0100 2244HSV-1+Rinbavirin of 1: 5 0,000 1,000 1,000 0000 2000FMW1+ throat lozenge of group 0h 5h 8h 10h 12hFM1 virus control 0,000 3,333 3,434 4444 4444FMW1+ throat lozenge, 1: 10 0,000 0,100 2,220 0220 2100FM1+Ribavirin, 1: 5 0,000 0,000 0,000 0000 3333HSV-1+ throat lozenge of 0,000 0,000 0,000 0000 0000HSV-1 virus control, 0,000 2,222 3,322 4444 4444HSV-1+ throat lozenge, 0,000 0,000 0,000 0,000 0000 normal cell control group 0,000 0,000 0,000 0,000 0000
Annotate: specificity fluorescent cell concentration: " 0 ": 0%; " 1 ":＜5%; " 2 ": 5-10%; " 3 ": 10-30; " 4 ":＞30%.
The result of table 2 shows that the 5th hour beginning of influenza virus FM1 strain after absorption has the cell quantity showed increased of specificity fluorescent, illustrates that virus has begun massive duplication, reaches high honeybee the 8th hour duplicating of virus.And give the experimental group of the Waterelon Frost Lozenges (being equivalent to crude drug 0.3 or 0.15) of 1: 5 or 1: 10, in whole viewing duration (after the virus absorption 5-12 hour), specificity fluorescent cell number very few (below the less than 5% or 10%), duplicating obviously of virus is obstructed.Herpes simplex virus I-type (HSV-1) peaked at virus absorption back beginning in the 8th hour massive duplication on the 10th hour, and in administration group the 10th hour after virus absorption, virus replication is stoped substantially, and virus replication was still a little less than matched group in the 12nd hour.
3. Waterelon Frost Lozenges is to the influence of mice influenza virus property pneumonia
After the mice random packet, in infecting preceding 1 day beginning ig administration, continuous 5 days.During infection with the influenza virus FM1 collunarium infecting mouse of 15 LD50.Infect the back and dissected mice (100 * lung weight/body weight) on the 4th day, compare between organizing.The lung exponential quantity is big more, and the pneumonopathy that expression virus causes becomes serious more.See Table 3.
Table 3 Waterelon Frost Lozenges (throat lozenge) is to the influence of mice influenza virus property pneumonia
Group dosage (g/kg.d) Mus number (only) lung index (suppression ratio (%) P value virus control 0 10 1.55 ± 0.23 0 throat lozenge 5 10 1.41 ± 0.16 12.22＜0.05 of X ± SD)
10 10 1.32±0.17 16.76 ＜0.01
20 10 1.27±0.14 19.33 ＜0.01Ribavirin 0.08 10 1.23±0.07 20.51 ＜0.01
As shown in Table 3, the Waterelon Frost Lozenges of various dose can suppress obviously all that influenza virus causes, pulmonary lesion, the corresponding decline of the lung value of giving advice with the logarithmic increase of dosage, and significant dose-effect relationship (Y=1.4923-0.1823X, r=0.9874, p＜0.05) is arranged.
4. Waterelon Frost Lozenges is to the influence of proliferation of influenza virus in the Mus lung
Begin administration the previous day in infecting to mice ig, for three days on end, with 1000LD50 influenza infection mice, get lung in infecting to dissect in back 48 hours, routine is made paraffin section, with indirect immunofluorescence dyeing, observe the bronchioles cross section percentage rate (specificity fluorescent ratio) that is specificity fluorescent in the lung sections, with the virus control group comparison of not administration.The result sends out sight, and Waterelon Frost Lozenges has stronger inhibitory action to the propagation of influenza virus in the Mus lung, and its suppression ratio is up to 34.16%-35.74%, and is higher than positive control drug Ribavirin.See Table 4.
Table 4 Waterelon Frost Lozenges (throat lozenge) is to the influence of proliferation of influenza virus in the Mus lung
Group dosage (g/kg.d) specificity fluorescent ratio (%) inhibiting rate (%) P value virus control 0 67.60 throat lozenges 5 44.61 34.16 P＜0.01 throat lozenge, 10 43.53 35.74 P＜0.01 throat lozenge, 20 43.65 35.42 P＜0.01Ribavirin 0.08 50.00 25.95 P＜0.01
In addition, virus multiplication curve and the medicine situation that influences to the virus multiplication process has also been observed in this research.The result shows that 48 hours lung inner virus amounts peak behind the viral infection, give 7g/kg Waterelon Frost Lozenges every day (ig), the propagation that then can obviously suppress virus, curve is smooth, does not see the peak in 48 hours, and is similar to the growth curve of positive control drug Ribavirin (70/mg/kg).
Embodiment:Get clean watermelon crystal 38kg, by water content 35% conversion, oven dry was pulverized 100 orders, more than the deserved fine powder 26kg.Get sucrose (or lactose or sorbitol or mannitol or maltose etc.) 1128.5kg, pulverized 80 mesh sieves, more than the deserved fine powder 1106kg, i.e. flour extraction 〉=98%.Get 115 ℃ of flowing steams of watermelon crystal powder, the 30min sterilization, oven dry makes moisture content≤1%, takes out, and is ground into fine powder.The operation recovery rate answers 〉=97%; Get watermelon crystal fine powder 26kg, cane sugar powder (or lactose powder or sorbitol powder or mannitol powder or maltitol powder etc.) 1106kg, dextrin 32.5kg, put and stir evenly in the blender more than 3 minutes, with 0.255kg carmine and 0.8kg citric acid, filter with an amount of dissolved in distilled water, the 30%-40%L mixed alkoxide solution that adds filtering carmine and citric acid stirs more than 8 minutes, making soft material granulates with 16 orders brocade logical sequence screen cloth, through boiling-bed drying or the oven dry of electric drying bed, make dried granule moisture content in 0.3%.With Borneolum Syntheticum 1.2kg, Mentholum 2.4kg is behind 95% dissolve with ethanol; with the 2.0kg Oleum menthae; 200ml flavoring orange essence mixing filters the back and adds in the granule, crosses the high speed pelletizing machine: the magnesium stearate that 0.5% granule is heavy; the silicon dioxide that 0.5% granule is heavy sucks in the V-Mixer with 3% Pulvis Talci and granule after crossing 100 mesh sieves; stir to pounce on and mixed 10 minutes, discharging is crossed 5 mesh sieves and is inhaled the ferrum bucket; pack in the clean bucket airtight 3 hours hours into.Granule is added in the tablet machine hopper, the start tabletting, the small pieces sheet heavily is 0.6g, should be pressed into 2,000,000 of small pieces.The heavy 1.2g of large stretch of sheet should be pressed into 1,000,000.
Claims (10)
1, a kind of Chinese medicine composition of preventing and treating throat and oral cavity diseases is characterized in that what said composition was made by following crude drug:
Watermelon crystal 19～90 weight portion Borneolum Syntheticums 0.01～1.5 weight portion
Oleum menthae 0.01～2.5 weight portion Mentholum 0.02～3 weight portion.
2, Chinese medicine composition as claimed in claim 1 is characterized in that said composition made by following crude drug:
Watermelon crystal 38 weight portion Borneolum Syntheticums 1.2 weight portions
Mentholum 2.4 weight portion Oleum menthaes 2.0 weight portions.
3, Chinese medicine composition as claimed in claim 1 or 2 is characterized in that said composition can add conventional adjuvant and make clinical acceptable forms.
4, Chinese medicine composition as claimed in claim 3 is characterized in that the said composition dosage form is a buccal tablet, effervescent tablet, oral liquid, drop pill, granule, paster, capsule, spray.
5, as preparation of drug combination method as described in the claim 4, it is characterized in that this method is: get clean watermelon crystal, the oven dry, pulverize fine powder, get sucrose or sorbitol or mannitol or lactose or maltose 900-1200 weight portion, pulverized 60～120 mesh sieves, must get the sterilization of watermelon crystal powder, oven dry is taken out, be ground into fine powder, the operation recovery rate answers 〉=97%; Get watermelon crystal fine powder 20-30 weight portion, cane sugar powder or sorbitol powder or mannitol powder or lactose powder or maltitol powder 1000-1200 weight portion, dextrin 20-40 weight portion, put and stir evenly 3～20 minutes in the blender,, filter with an amount of dissolved in distilled water with 0.1-0.3 weight portion carmine and 0.6-1 weight portion citric acid, the 30%-40% alcohol mixed solution that adds filtering carmine and citric acid weight portion stirs more than 6-10 minute, granulate, drying makes dried granule moisture content in 0.3%; With Borneolum Syntheticum, Mentholum, behind 95% dissolve with ethanol, with Oleum menthae, the essence mixing, filtering the back adds in the granule, cross pelletizing machine, the magnesium stearate that the 0.2-1% granule is heavy, the silicon dioxide that the 0.2-1% granule is heavy sucks in the V-Mixer with 1-4% Pulvis Talci and granule after crossing 60～150 mesh sieves, mixed 5～15 minutes, airtight more than 2～5 hours hours; Granule is pressed into tablet.
6, as preparation of drug combination method as described in the claim 5, it is characterized in that this method is:
Get clean watermelon crystal 38 weight portions, by water content 35% conversion, oven dry was pulverized 100 orders, more than deserved fine powder 26 weight portions; Get sucrose or sorbitol or mannitol or lactose or maltose 1128.5 weight portions, pulverized 80 mesh sieves, more than deserved fine powder 1106 weight portions, i.e. flour extraction 〉=98%; Get 115 ℃ of flowing steams of watermelon crystal powder, the 30min sterilization, oven dry makes moisture content≤1%, takes out, and is ground into fine powder; The operation recovery rate answers 〉=97%; Get watermelon crystal fine powder 26 weight portions, cane sugar powder or sorbitol powder or mannitol powder or lactose powder or maltitol powder 1106 weight portions, dextrin 32.5 weight portions, put and stir evenly in the blender more than 3 minutes, with 0.255 weight portion carmine and 0.8 weight portion citric acid, filter with an amount of dissolved in distilled water, the 30%-40% alcohol mixed solution that adds filtering carmine and citric acid stirs more than 8 minutes, making soft material granulates with 16 orders brocade logical sequence screen cloth, through boiling-bed drying or the oven dry of electric drying bed, make dried granule moisture content in 0.3%; With Borneolum Syntheticum 1.2 weight portions, Mentholum 2.4 weight portions behind 95% dissolve with ethanol, with 2.0 weight portion Oleum menthaes, 200ml flavoring orange essence mixing, filter the back and add in the granule, cross the high speed pelletizing machine; The magnesium stearate that 0.5% granule is heavy, the silicon dioxide that 0.5% granule is heavy sucks in the V-Mixer with 3% Pulvis Talci and granule after crossing 100 mesh sieves, mixes 10 minutes, and discharging is crossed 5 mesh sieves and is inhaled the ferrum bucket, in the clean bucket of packing into, more than airtight 3-4 hour; Granule is added in the tablet machine hopper, and compacting in flakes.
7, the application of pharmaceutical composition as claimed in claim 1 or 2 in antibiotic, the anti-inflammation drugs of preparation.
8, the application of pharmaceutical composition as claimed in claim 1 or 2 in the medicine of preparation treatment chronic pharyngitis.
9, the application of pharmaceutical composition as claimed in claim 1 or 2 in the preparation antiviral drugs.
10, application as claimed in claim 9 is characterized in that described virus is meant that influenza virus, adenovirus or herpes simplex disease are mould.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02158103 CN1205972C (en) | 2002-12-23 | 2002-12-23 | Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02158103 CN1205972C (en) | 2002-12-23 | 2002-12-23 | Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1422663A true CN1422663A (en) | 2003-06-11 |
| CN1205972C CN1205972C (en) | 2005-06-15 |
Family
ID=4753074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02158103 Expired - Lifetime CN1205972C (en) | 2002-12-23 | 2002-12-23 | Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1205972C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100387268C (en) * | 2005-12-29 | 2008-05-14 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal preduct for preventing and treating aphtha and its manufacturing method |
| CN100391496C (en) * | 2005-12-29 | 2008-06-04 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal product for preventing and treating toothache and its manufacturing method |
| CN101773538A (en) * | 2010-03-11 | 2010-07-14 | 艾汝彬 | External application medicine for treating acute pharyngitis |
| CN102755369A (en) * | 2011-04-26 | 2012-10-31 | 桂林三金药业股份有限公司 | Traditional Chinese medicine composition used for treating oral diseases, preparation process thereof, and quality detection method thereof |
| CN104687059A (en) * | 2015-03-31 | 2015-06-10 | 刘波 | Oral health-care lozenges |
| CN104706858A (en) * | 2015-03-31 | 2015-06-17 | 刘波 | Oral cavity health spray and preparation method thereof |
| CN105963533A (en) * | 2016-07-12 | 2016-09-28 | 杨高林 | Preparation method of traditional Chinese medicine for treating chronic pharyngitis and traditional Chinese medicine buccal tablet |
| CN108888650A (en) * | 2018-08-26 | 2018-11-27 | 卓小玲 | A kind of composition and preparation method thereof for treating canker sore |
-
2002
- 2002-12-23 CN CN 02158103 patent/CN1205972C/en not_active Expired - Lifetime
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100387268C (en) * | 2005-12-29 | 2008-05-14 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal preduct for preventing and treating aphtha and its manufacturing method |
| CN100391496C (en) * | 2005-12-29 | 2008-06-04 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal product for preventing and treating toothache and its manufacturing method |
| CN101773538A (en) * | 2010-03-11 | 2010-07-14 | 艾汝彬 | External application medicine for treating acute pharyngitis |
| CN101773538B (en) * | 2010-03-11 | 2011-06-08 | 艾汝彬 | External application medicine for treating acute pharyngitis |
| CN102755369A (en) * | 2011-04-26 | 2012-10-31 | 桂林三金药业股份有限公司 | Traditional Chinese medicine composition used for treating oral diseases, preparation process thereof, and quality detection method thereof |
| CN102755369B (en) * | 2011-04-26 | 2014-11-19 | 桂林三金药业股份有限公司 | Traditional Chinese medicine composition used for treating oral diseases, preparation process thereof, and quality detection method thereof |
| CN104687059A (en) * | 2015-03-31 | 2015-06-10 | 刘波 | Oral health-care lozenges |
| CN104706858A (en) * | 2015-03-31 | 2015-06-17 | 刘波 | Oral cavity health spray and preparation method thereof |
| CN105963533A (en) * | 2016-07-12 | 2016-09-28 | 杨高林 | Preparation method of traditional Chinese medicine for treating chronic pharyngitis and traditional Chinese medicine buccal tablet |
| CN108888650A (en) * | 2018-08-26 | 2018-11-27 | 卓小玲 | A kind of composition and preparation method thereof for treating canker sore |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1205972C (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101700307B (en) | Traditional Chinese medicine for curing chronic pharyngolaryngitis | |
| CN1724040A (en) | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method | |
| CN1205972C (en) | Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method | |
| CN1150927C (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
| CN100350931C (en) | Chinese medicine liniment for treating toothache and its preparing method | |
| CN1151807C (en) | Chinese-medicinal spray for treating chronic pharyngolaryngitis and its preparing process | |
| CN1762425A (en) | Efervescence tablet with kudzuvine root, scutellarta root, Chinese goldthread and its preparation method | |
| CN1104246C (en) | Fumigant lotion for treating anorectal disease and preparing process thereof | |
| CN1350868A (en) | Medicine for preventing and treating cold and its preparing process | |
| CN1167453C (en) | A powder for the treatment of hemorrhoid | |
| CN1291730C (en) | Chinese medicine for preventing and treating SARS virus | |
| CN103599440A (en) | Traditional Chinese medicine combination containing mango leaf | |
| CN1425441A (en) | Compound macrostem onion preparation for curing chronic obstructive lung disease and its preparing method | |
| CN102205048A (en) | Pharmaceutical composition with function of moistening throat | |
| CN1172696C (en) | Medicine for preventing acute upper respiratory tract infection of children group | |
| CN102228560A (en) | Medicine for treating chronic pharyngitis | |
| CN1223373C (en) | Sore throat relieving preparation | |
| CN1250257C (en) | Granule for clearing away the lung-heat and removing poison | |
| CN1253184C (en) | A Chinese medicinal composition for treating pharyngolaryngitis, and its preparation method | |
| CN1546147A (en) | Effervescence tablet for treating children's cough and asthma and its preparation | |
| CN1103599C (en) | Chenxia medicament for relieving asthma and its pren. tech. | |
| CN1234395C (en) | Medicinal tea of infused in boiling water and its production method | |
| CN1292763C (en) | Chinese traditional medicine buccal tablets for preventing and treating caries and its preparation | |
| CN1742799A (en) | Copmound effervescent preparation for treating upper respiratang tract inflammation and producing method | |
| CN1268360C (en) | Pathogenic fire purging Chinese medicinal tablet containing borneol and nantural oindigo and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: GUILIN SANJIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZOU JIEMING Effective date: 20030815 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20030815 Applicant after: GUILIN SANJIN PHARMACEUTICAL Co.,Ltd. Applicant before: Zou Jieming |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050615 |
|
| CX01 | Expiry of patent term |